LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 24 | 3504 | 0.0068 | 0.0440 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 2053 | 3504 | 0.5859 | 0.8653 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 9 | 3504 | 0.0026 | -0.0814 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 2121 | 3504 | 0.6053 | 0.8732 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 1928 | 3504 | 0.5502 | 0.8501 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.45 | 17.25 | 2192 | 3504 | 0.6256 | 0.8813 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 23 | 3895 | 0.0059 | 0.0375 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 2222 | 3895 | 0.5704 | 0.8614 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 3 | 3895 | 0.0008 | -0.2005 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 2255 | 3895 | 0.5788 | 0.8649 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 2125 | 3895 | 0.5455 | 0.8508 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.42 | 17.25 | 2314 | 3895 | 0.5940 | 0.8711 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 36 | 4141 | 0.0087 | 0.0975 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 2400 | 4141 | 0.5795 | 0.8667 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 5 | 4141 | 0.0012 | -0.1450 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 2439 | 4141 | 0.5889 | 0.8705 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 2315 | 4141 | 0.5590 | 0.8582 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.39 | 17.25 | 2480 | 4141 | 0.5988 | 0.8744 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 29 | 4390 | 0.0066 | 0.0672 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 2523 | 4390 | 0.5747 | 0.8661 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 10 | 4390 | 0.0023 | -0.0660 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 2599 | 4390 | 0.5920 | 0.8730 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 2370 | 4390 | 0.5398 | 0.8515 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.36 | 17.25 | 2614 | 4390 | 0.5954 | 0.8744 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 50.33 | 17.25 | 34 | 4651 | 0.0073 | 0.0877 | MN20160310_N02 | H19 |